Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: A link between the apoptosome and the proteasome pathway

Journal of Experimental Medicine

Volumn 189, Issue 11, 1999, Pages 1815-1822

  Dimmeler, Stefanie ^a   Breitschopf, Kristin ^a   Haendeler, Judith ^a   Zeiher, Andreas M ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Apoptosis; Bcl 2; Endothelial cells; Mitogen activated protein kinase; Proteasome

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEASOME; PROTEIN BCL 2; UBIQUITIN;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; DEPHOSPHORYLATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0033532543     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.11.1815     Document Type: Article

References (40)

1. Corcoran, G.B., L. Fix, D.P. Jones, M.T. Moslen, P. Nicotera, F.A. Oberhammer, and R. Buttyan. 1994. Apoptosis: molecular control point in toxicity. Toxicol. Appl. Pharmacol. 128:169-181.
2. Dimmeler, S., J. Haendeler, J. Galle, and A.M. Zeiher. 1997. Oxidized low density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases: a mechanistic clue to the response to injury hypothesis. Circulation. 95:1760-1763.
3. Dimmeler, S., J. Haendeler, M. Nehls, and A.M. Zeiher. 1997. Suppression of apoptosis by nitric oxide via inhibition of ICE-like and CPP32-like proteases. J. Exp. Med. 185:601-608.
4. Dimmeler, S., and A.M. Zeiher. 1998. Apoptosis of endothelial cells. Contribution to the pathophysiology of atherosclerosis? Eur. Cytokine Netw. 9:697-698.
5. Haimovitz-Friedman, A., C. Cordon-Cardo, S. Bayoumy, M. Garzotto, M. McLoughlin, R. Gallily, C.K. Edwards III, E.H. Schuchman, Z. Fuks, and R. Kolesnick. 1997. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J. Exp. Med. 186:1831-1841.
6. Sata, M., and K. Walsh. 1998. Oxidized LDL activates fasmediated endothelial cell apoptosis. J. Clin. Invest. 102:1682-1689.
7. Cohen, J.J. 1993. Apoptosis. Immunol. Today. 14:126-130.
8. White, E. 1996. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1-15.
9. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355-365.
10. Kroemer, G. 1997. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:614-620.
11. Reed, J.C. 1997. Double identity for proteins of the Bcl-2 family. Nature. 387:773-776.
12. Zou, H., W.J. Henzel, X. Liu, A. Lutschg, and X. Wang. 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 90:405-413.
13. Green, D.R. 1998. Apoptotic pathways: the road to ruin. Cell. 94:695-698.
14. Muzio, M., A.M. Chinnaiyan, F.C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J.D. Bretz, M. Zhang, R. Gentz, M. Mann, P.H. Krammer, M.E. Peter, and V.M. Dixit. 1996. FLICE, a novel FADD-homologous ICE/ CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 85:817-827.
15. Li, P., D. Nijhawan, I. Budihardjo, S.M. Srinivasula, M. Ahmad, E.S. Alnemri, and X. Wang. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:479-489.
16. Srinivasula, S.M., M. Ahmad, T. Fernandes-Alnemri, and E.S. Alnemri. 1998. Autoactivation of procaspase-9 by Apaf-1-mediated oligomenzation. Mol. Cell. 1:949-957.
17. Kluck, R.M., E. Bossy-Wetzel, D.R. Green, and D.D. Newmeyer. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1132-1136.
18. Yang, J., X. Liu, K. Bhalla, C.N. Kim, A.M. Ibrado, J. Cai, T.-I. Peng, D.P. Jones, and X. Wang. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1129-1132.
19. Haendeler, J., U.K. Messmer, B. Brüne, E. Neugebauer, and S. Dimmeler. 1996. Endotoxic shock leads to apoptosis in vivo and reduces Bcl-2. Shock. 6:405-409.
20. Leri, A., Y. Liu, A. Malhotra, Q. Li, P. Stiegler, P.P. Claudio, A. Giordano, J. Kajstura, T.H. Hintze, and P. Anversa. 1998. Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes. Circulation. 97:194-203.
21. Isenmann, S., G. Stoll, M. Schroeter, S. Krajewski, J.C. Reed, and M. Bahr. 1998. Different regulation of Bax, Bcl-2 and Bc1-X proteins in focal cortical ischemia in the rat. Brain Pathol 8:49-62.
22. Haendeler, J., A.M. Zeiher, and S. Dimmeler. 1996. Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax. Eur. J. Phamacol. 317:407-411.
23. Paradis, E., H. Doulliard, M. Koutroumanis, C. Goodyer, and A. LeBlanc. 1996. Amyloid β peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons. J. Neurosci. 16:7533-7539.
24. Ciechanover, A. 1994. The ubiquitin-proteasome proteolytic pathway. Cell. 79:13-21.
25. Ciechanover, A. 1994. The ubiquitin-mediated proteolytic pathway: mechanisms of action and cellular physiology. Biol. Chem. Hoppe-Seyler. 375:565-581.
26. Hochstrasser, M. 1996. Protein degradation or regulation: Ub the judge. Cell. 84:813-815.
27. Weissman, A.M. 1997. Regulating protein degradation by ubiquitination. Immunol. Today. 18:189-198.
28. Maki, C.G., J.M. Huibregtse, and P.M. Howley. 1996. In vivo ubiquitination and proteasome-mediated degradation of p53. Cancer Res. 56:2649-2654.
29. Scheffner, M., U. Nuber, and J.M. Huibregtse. 1995. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature. 373:81-83.
30. Musti, A.M., M. Treier, and D. Bohmann. 1997. Reduced ubiquitin-dependent degradation of c-jun after phosphorylation by MAP-kinases. Science. 275:400-402.
31. Palombella, V.J., O.J. Rando, A.L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-kappaB1 precursor protein and the activation of NF-kappaB. Cell. 78:773-785.
32. Dimmeler, S., B. Assmus, C. Hermann, J. Haendeler, and A.M. Zeiher. 1998. Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. Circ. Res. 83:334-342.
33. Fenteany, G., R.F. Standaert, W.S. Lane, S. Choi, E.J. Corey, and S.L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science. 268:726-731.
34. Krappmann, D., F.G. Wulczyn, and C. Scheidereit. 1996. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor I-kappaBalpha in vivo. EMBO (Eur. Mol Biol. Organ.) J. 15:6716-6726.
35. Fan, C.M., and T. Maniatis. 1991. Generation of p50 subunit of NF-kappa B by processing of p 105 through an ATP-dependent pathway. Nature. 354:395-398.
36. Cheng, E.H.-Y., D.G. Kirsch, R.J. Clem, R. Ravi, M.B. Kastan, A. Bedi, K. Ueno, and J.M. Hardwick. 1997. Conversion of Bcl-2 to Bax-like death effector by caspases. Science. 278:1966-1968.
37. Horiuchi, M., W. Hayashida, T. Kambe, T. Yamada, and V.J. Dzau. 1997. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J. Biol. Chem. 272: 19022-19026.
38. Camps, M., A. Nichols, C. Gillieron, B. Antonsson, M. Muda, C. Chabert, U. Boschert, and S. Arkinstall. 1998. Catalytic activation of the phosphatase MKP-3 by ERK-2 mitogen-activated protein kinase. Science. 280:1262-1265.
39. Muda, M., U. Boschert, R. Dickinson, J.C. Martinou, I. Martinou, M. Camps, W. Schlegel, and S. Arkinstall. 1996. MKP-3, a novel cycosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J. Biol. Chem. 271:4319-4326.
40. Reed, J.C. 1997. Cytochrome c: can't live with it-can't live without it. Cell. 91:559-562.